Perceive Pharma Attracts $15M Series A Financing to Advance Ophthalmic Neuroprotection
Funding to fuel company’s progress in driving lead glaucoma program to clinical readiness; industry veteran, Dr. Carol Gallagher, joins Board SOUTH SAN FRANCISCO, Calif., Feb. 18, 2025 /PRNewswire/ — Perceive Pharma, a pharmaceutical company pioneering novel small molecule therapeutics…